A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

December 30, 2019

Study Completion Date

August 1, 2024

Conditions

Women at Risk for Pregnancy

Interventions

DRUG

VeraCept

VeraCept Intrauterine Device (IUD)

DRUG

ParaGard

ParaGard intrauterine copper contraceptive

Trial Locations (2)

OHSU Women's Health Research Unit, Portland

Seattle Women's Health, Seattle

All Listed Sponsors

collaborator

Synteract, Inc.

INDUSTRY

lead

Sebela Women's Health Inc.

INDUSTRY

NCT03785366 - A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs) | Biotech Hunter | Biotech Hunter